BioVaxys and SpayVac-for-Wildlife Expand License Agreement to Aquaculture Market
BioVaxys Technology Corp. and SpayVac-for-Wildlife have broadened their license agreement to include commercial aquaculture, potentially opening significant revenue opportunities in the global fish farming market through innovative fertility-control vaccine technology.
